Flamini E - Search Results

1

Clinical and laboratory evaluation of the myeloprotective effect of medroxyprogesterone acetate in head and neck cancer.

Amadori D, Frassineti GL, Flamini E, Falcini F, Maltoni M, Nanni O, Riccobon A, Piccinini C. Amadori D, et al. Among authors: flamini e. Eur J Cancer. 1992;28A(8-9):1331-4. doi: 10.1016/0959-8049(92)90511-y. Eur J Cancer. 1992. PMID: 1381210 Clinical Trial.

2

Evaluation of toxicity in 22 patients treated with subcutaneous interleukin-2, alpha-interferon with and without chemotherapy.

Ridolfi R, Maltoni R, Riccobon A, Flamini E, Amadori D. Ridolfi R, et al. Among authors: flamini e. J Chemother. 1992 Dec;4(6):394-8. doi: 10.1080/1120009x.1992.11739198. J Chemother. 1992. PMID: 1287142

3

A phase II study of advanced colorectal cancer patients treated with combination 5-fluorouracil plus leucovorin and subcutaneous interleukin-2 plus alpha interferon.

Ridolfi R, Maltoni R, Riccobon A, Flamini E, Fedriga R, Milandri C, Pezzi L, Velotti F, Santoni A, Amadori D. Ridolfi R, et al. Among authors: flamini e. J Chemother. 1994 Aug;6(4):265-71. doi: 10.1080/1120009x.1994.11741163. J Chemother. 1994. PMID: 7830105 Clinical Trial.

4

Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients.

Maltoni M, Fabbri L, Nanni O, Scarpi E, Pezzi L, Flamini E, Riccobon A, Derni S, Pallotti G, Amadori D. Maltoni M, et al. Among authors: flamini e. Support Care Cancer. 1997 Mar;5(2):130-5. doi: 10.1007/BF01262570. Support Care Cancer. 1997. PMID: 9069613

5

Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients.

Ridolfi R, Flamini E, Riccobon A, De Paola F, Maltoni R, Gardini A, Ridolfi L, Medri L, Poletti G, Amadori D. Ridolfi R, et al. Among authors: flamini e. Cancer Immunol Immunother. 1998 Jun;46(4):185-93. doi: 10.1007/s002620050477. Cancer Immunol Immunother. 1998. PMID: 9671141 Free PMC article.

6

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.

De Paola F, Ridolfi R, Riccobon A, Flamini E, Barzanti F, Granato AM, Mordenti GL, Medri L, Vitali P, Amadori D. De Paola F, et al. Among authors: flamini e. Br J Cancer. 2003 Jan 27;88(2):320-6. doi: 10.1038/sj.bjc.6600679. Br J Cancer. 2003. PMID: 12610520 Free PMC article.

7

Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma.

Ridolfi L, Ridolfi R, Riccobon A, De Paola F, Petrini M, Stefanelli M, Flamini E, Ravaioli A, Verdecchia GM, Trevisan G, Amadori D. Ridolfi L, et al. Among authors: flamini e. J Immunother. 2003 Mar-Apr;26(2):156-62. doi: 10.1097/00002371-200303000-00008. J Immunother. 2003. PMID: 12616107

8

[Relationship between cytosol CEA and clinico-pathologic and biologic parameters in 167 cases if primary carcinoma of the breast].

Riccobon A, Frassineti L, Vasini M, Volpi A, Pallotti G, Flamini E, Magni E, Nunziatini R, Amadori D. Riccobon A, et al. Among authors: flamini e. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):27-8. J Nucl Med Allied Sci. 1990. PMID: 2092130 Italian. No abstract available.

9

Radioligand-labeled binding assay and immunochemical assay for estrogen receptor in 115 human breast cancers.

Riccobon A, Zoli W, Capucci A, Volpi A, Vasini M, Bonaguri C, Flamini E, Ravaioli A, Amadori D. Riccobon A, et al. Among authors: flamini e. Tumori. 1988 Apr 30;74(2):167-70. doi: 10.1177/030089168807400208. Tumori. 1988. PMID: 3285555

10

Immunosuppression in renal cancer: differential expression of signal transduction molecules in tumor-infiltrating, near-tumor tissue, and peripheral blood lymphocytes.

Riccobon A, Gunelli R, Ridolfi R, De Paola F, Flamini E, Fiori M, Saltutti C, Petrini M, Fiammenghi L, Stefanelli M, Granato AM, Cuzzocrea DE, Amadori D. Riccobon A, et al. Among authors: flamini e. Cancer Invest. 2004;22(6):871-7. doi: 10.1081/cnv-200039653. Cancer Invest. 2004. PMID: 15641485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters